RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Norrie Disease: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Early Clinical Manifestations and Visual Prognosis of Japanese Patients with Norrie Disease: A Case Series and Literature Review.
Futami Takuma et al., Journal of clinical medicine (21 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42796096/
- 2.
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy.
Dillinger Andrea E et al., Molecular therapy. Advances (10 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42436854/
- 3.
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy
Andrea E. Dillinger et al., University of Regensburg Publication Server (University of Regensburg) (13 July 2026)
https://doi.org/10.5283/epub.79779
- 4.
A novel variant of the NPD gene results in Norrie disease in a Vietnamese patient
Khanh V. Vu Nguyen et al., Vietnam Journal of Biotechnology (28 April 2026)
https://doi.org/10.15625/vjbt-24007
- 5.
Norrie Disease - An Overview
Shahmeer Hamid, Journal of the Foundations of Ophthalmology (18 January 2026)
https://doi.org/10.48089/jfo7689109
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Norrie Disease
Norrie disease is a rare inherited condition caused by changes in the NDP gene on the X chromosome, so it almost always affects boys. The retina fails to develop normally, causing blindness from birth or early infancy, and many people also develop progressive hearing loss and sometimes developmental or behavioural difficulties. Care focuses on early hearing monitoring and aids, vision and developmental support, and treatment of eye complications.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Background/Objectives: To characterize the early clinical manifestations and treatment outcomes of Japanese patients with Norrie disease. Retrospective multicenter observational case series with a systematic literature review. Methods: Fourteen infants with genetically confirmed Norrie disease were retrospectively reviewed. Clinical findings, disease stage, interocular asymmetry, treatment, and visual outcomes were evaluated using a modified staging system based on familial exudative vitreoretinopathy (FEVR) and the International Classification of Retinopathy of Prematurity. A systematic review of previously reported Japanese cases was performed to assess disease severity at initial diagnosis. Results: Twenty-eight eyes of 14 patients were included. The median age at the initial examination was 2.5 months. Twenty-three eyes (82%) had stage 5 retinal detachment, whereas only five eyes (18%) had stage 2 or 4 disease. Interocular asymmetry was uncommon. Twenty-one eyes (75%) underwent laser photocoagulation and/or surgery. Visual outcomes were poor; at the most recent follow-up, all but two stage 4 eyes treated with laser photocoagulation had no light perception. Combined analysis of our cohort and the literature review identified 29 Japanese patients from 19 families and demonstrated that most already had advanced bilateral retinal detachment within the first two months of life. Conclusions: Norrie disease typically presents with advanced bilateral retinal detachment during early infancy, leaving limited opportunities for effective intervention. Early recognition and genetic diagnosis are therefore essential.
Common Questions
What is Norrie Disease?
Norrie disease is a rare inherited condition caused by changes in the NDP gene on the X chromosome, so it almost always affects boys. The retina fails to develop normally, causing blindness from birth or early infancy, and many people also develop progressive hearing loss and sometimes developmental or behavioural difficulties. Care focuses on early hearing monitoring and aids, vision and developmental support, and treatment of eye complications.
How many clinical trials are available for Norrie Disease?
No clinical trials are currently indexed for Norrie Disease. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Norrie Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Norrie Disease.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.